Lutetium Lu 177 Dotatate Dosage Guide
Complete guide to Lutetium Lu 177 Dotatate dosing protocols, administration methods, and safety considerations for research purposes.
Detailed Dosage Information
Prescription-only medicine.
Dosing is set by a physician according to the FDA-approved label and the condition being treated.
Administration Method
Administration details not available for this peptide.
Research Backing
FDA prescribing information (Lutathera). NETTER-1 phase 3 trial (NEJM 2017).
Side Effects to Monitor
Low blood counts, nausea, vomiting, fatigue, raised liver enzymes and low potassium.
Safety Considerations & Risks
Radiation exposure, bone marrow suppression, a small risk of secondary blood cancers (myelodysplastic syndrome, leukemia), kidney toxicity, hormonal crises from tumor release, and harm to a fetus. Requires radiation safety precautions.